BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3960380)

  • 21. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytologic picture of smears from the cervix uteri of women using intrauterine contraceptive devices (IUD)].
    Wagrowska-Danilewicz M; Gwóźdź AZ; Danilewicz M
    Ginekol Pol; 1988 Dec; 59(12):724-7. PubMed ID: 3254840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of precancerous and early cancerous lesions of the uterine cervix.
    Luthra UK; Prabhakar AK; Seth P; Agarwal SS; Murthy NS; Bhatnagar P; Das DK; Sharma BK
    Acta Cytol; 1987; 31(3):226-34. PubMed ID: 3035845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of premalignant lesions of the cervix uteri. Comparative study between a female population using contraceptives].
    Arizaga Cruz JM; García González J; Garrido Cuevas M; Ortíz Díaz C
    Ginecol Obstet Mex; 1979 Jul; 46(273):37-44. PubMed ID: 527851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premalignant lesions of the cervix in women of Cali, Colombia.
    Duque E; Cuello C; Aristizábal N; Haenszel W; Botero S; Correa P
    J Natl Cancer Inst; 1979 Oct; 63(4):953-63. PubMed ID: 480388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper containing intrauterine devices and cervical carcinogenesis--48 months follow up.
    Luthra UK; Mitra AB; Prabhakar AK; Bhatnagar P; Agarwal SS
    Indian J Med Res; 1980 Nov; 72():659-64. PubMed ID: 7203566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of endometrial cells in cervical smears in relation to the use of intrauterine devices].
    Alcaino I; Bierschwale M
    Rev Chil Obstet Ginecol; 1976; 41(2):95-8. PubMed ID: 1013438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Actinomyces-like organisms in users of intrauterine contraception].
    Kozuh M; Bonta S; Kovacic J; Levicnik A; Lushi A
    Jugosl Ginekol Opstet; 1984; 24(5-6):87-91. PubMed ID: 6535891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of cervical neoplasia and infection in women using intrauterine contraceptive devices.
    Blenkinsopp WK; Chapman P
    J Reprod Med; 1982 Nov; 27(11):709-13. PubMed ID: 7153984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [IUDs and ectopic pregnancy].
    Sivin I
    Contracept Fertil Sex (Paris); 1983 Dec; 11(12):1287-94. PubMed ID: 12312723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endocervical and vaginal changes in women wearing IUD's].
    Botta G; Cerrato G; Corongiu F
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):251-9. PubMed ID: 7137763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory changes and cervical intraepithelial neoplasia in IUD users.
    Bulgaresi P; Confortini M; Galanti L; Gargano D
    Cervix Low Female Genital Tract; 1989; 7(3):207-12. PubMed ID: 12283856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Foundations for differential cytology of cervical changes. 3. Dysplasia and carcinoma in situ (author's transl)].
    Höffken H; Rummel HH
    Zentralbl Gynakol; 1981; 103(24):1517-36. PubMed ID: 7340303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical changes associated with progestagen-only contraceptives: a team approach.
    Darwish A; Labeeb S; Galal M; Rashad H; Hassan S
    Contraception; 2004 Feb; 69(2):121-7. PubMed ID: 14759616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic pregnancy and intrauterine contraceptive devices: new perspectives. The Women's Health Study.
    Ory HW
    Obstet Gynecol; 1981 Feb; 57(2):137-44. PubMed ID: 7465116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of actinomycetes infection in women using intrauterine contraceptive devices.
    Nayar M; Chandra M; Chitraratha K; Kumari Das S; Rai Chowdhary G
    Acta Cytol; 1985; 29(2):111-6. PubMed ID: 3856980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proliferative mucosal changes of the corpus and cervix uteri in women using intrauterine contraceptives].
    Petrov IuA; Kovaleva EA
    Vopr Onkol; 1986; 32(3):49-52. PubMed ID: 3962257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.